rhodamine 123 has been researched along with rubimaillin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JH; Jeong, HG; Kim, HG; Na, MK; Tran, TP | 1 |
Siwei, Z; Xuguang, H; Yousheng, L; Zhen, W; Zhi, Z | 1 |
2 other study(ies) available for rhodamine 123 and rubimaillin
Article | Year |
---|---|
Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; NF-kappa B; Proto-Oncogene Proteins c-akt; Pyrans; Rhodamine 123 | 2013 |
Rubimaillin decreases the viability of human ovarian cancer cells via mitochondria-dependent apoptosis.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Mitochondria; Poly (ADP-Ribose) Polymerase-1; Pyrans; Rhodamine 123 | 2019 |